OSTX shareholders approve 200M share increase, Ayala issuance, and plan amendment at annual meeting

OS Therapies Inc

Charter amendment to increase authorized shares from 50M to 150M approved with 12.6M For, 228K Against, 16.3K Abstain.
Ayala Issuance (shares/warrants equal to ≥20% of outstanding common stock) approved with 12.7M For, 112.5K Against.
Plan Amendment increasing shares available for issuance from 4M to 10M and raising individual performance-based cap approved (10.9M For, 1.9M Against).
All six director nominees elected: Paul Romness, John Ciccio, Avril McKean Dieser, Karim Galzahr, Olivier Jarry, Theodore Search.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.